Colon Cancer
Studies from Democritus University in the area of colon cancer described
Published in Medical Device Business Week, September 5th, 2007
"The complex effect on anti-VEGF (vascular endothelial growth factor) monoclonal antibodies on the tumor vasculature urges studies to identify the optimal time frames for the administration of such agents with chemotherapy and radiotherapy. Using CT scan functional imaging, we examined the perfusion changes of contrast medium induced 7 days following administration of bevacizumab (5 mg/kg iv) in 12 patients with colorectal cancer. CT imaging 7 days after the administration of bevacizumab confinned tumor shrinkage in 3 of 12 cases," researchers in Greece report.
"The mean Haunsfield units after the injection of contrast medium were significantly lower 7 days following...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Adenoma
Fastest Parathyroid Hormone Test Cleared for Use During Parathyroid Surgeries - Artificial Enzymes
Researchers Evolve Artificial Enzymes in the Laboratory - Bioartificial Liver
Internationally Renowned Artificial Organs Expert Joins HepaLife - Bioengineering
Athersys Reports Second Quarter 2007 Financial Results - Bioengineering
GPC Biotech Announces Restructuring - Bioengineering
ImaRx Therapeutics to Study Permeability of Blood-Brain Barrier Using Microbubbles & Ultrasound Under NIH Grant - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
